A novel role of the splenic volume in Crohn's disease: evaluating the efficacy of infliximab
Background: A number of patients with Crohn's disease (CD) suffer from loss of response to infliximab (IFX) therapy. Splenic volume is reported to be enlarged in patients with CD compared to normal individuals. The association between splenic volume and IFX efficacy in CD remains unclear.Method...
Saved in:
Main Authors: | Xuan Shi (Author), Jia-Hui Wang (Author), Sheng-Xiang Rao (Author), Tao-Tao Liu (Author), Hao Wu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metastatic Crohn's disease despite infliximab therapy
by: Sara Campos, et al.
Published: (2017) -
Infliximab-induced intertriginous psoriasis in patient with Crohn's desease
by: Federica Mola, et al.
Published: (2011) -
Profile of infliximab in the treatment of pediatric Crohn’s disease
by: Kierus J, et al.
Published: (2015) -
Tuberculose esplênica durante tratamento de psoríase com infliximabe Splenic tuberculosis during psoriasis treatment with infliximab
by: Gleyce Tavares de Melo Fortaleza, et al.
Published: (2009) -
The Association Between Genetic Variants, Pharmacokinetics, and Infliximab Efficacy in Pediatric Patients With Crohn's Disease in China
by: Wenhui Hu, et al.
Published: (2021)